Table 2.

Articles on Normal Responder Patients

Article	N	Patients	Groups	Luteal Support	Statistically significant results (p<0,05)
Decleer W. et al. 2014, Belgium Prospective randomized	120	Normal Responders	G1) hCG alone; G2) Dual Trigger hCG: PregnylR 5000UI Agonist: GonapeptylR 0.2mg	UtrogestanR, 600mg. vv	G2: > number of patients with at least one top quality embryo (%) (73.8 vs. 47.5); > number of patients with embryos for cryopreservation (54.1 vs. 35.6)
Kim C.H. et al. 2014. Korea Prospective Randomized	120	Normal Responders	G1) Dual Trigger G2) hCG alone. (Doses: not related)	Progesterone (Doses: is not described)	G1 : >Implantation rate (%) (24.7 vs. 14.9); >  Pregnancy rate/cycle (%) (53.3 vs. 33.3); > live birth rate (%) (50.0 vs. 30.0)
Lin M.H. et al. 2013, Taiwan Retrospective Cohort	376	Normal Responders	G1) Dual Trigger; G2) hCG alone hCG: OvidrelR, 250ug Agonist DecapeptylR 0,2mg	P,50mg,d, IM + UtrogestanR, 300mg, vv	G1: > number of retrieved oocytcs (12.36±6.64 vs 10.10±4.58); > number of oocytes MII (10.531±6.47 vs. 8.03±4.51);> number of cryopreserved embryo (1.97±0.12 vs. 1.601±0.49); > Implantation rate (%) (29.68 vs. 18.43); > Pregnancy rate/Embryo Transfer (%) (41.36 vs. 30.49)
Bulut H. et al. 2015. Turkey Prospective Randomized. Double Bind	400	Normal Responders	G1) Dual Trigger; G2) hCG alone. hCG: OvitrclleR 6.500IU; Agonist: Triptorelin acetate. 0,2mg	Progesterone (Dose: ?)	It has not been published yet.